Arkolith/Insider Trading/ANGN/Form 4

Goldberg Itzhak

See Remarks, DirectorAngion Biomedica Corp. (ANGN) · full profile →Form 4 · filed Dec 3, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$410K
Net Open-Market Flow
-$410K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 3, 2021Sell(S)40K$3.39$136K1.8M
Dec 2, 2021Sell(S)39K$3.51$136K1.8M
Dec 1, 2021Sell(S)39K$3.54$138K1.8M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001601485-21-000079) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML